IRIS
MORBELLI, SILVIA DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 32.935
AS - Asia 4.508
NA - Nord America 3.261
SA - Sud America 405
AF - Africa 90
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 41.212
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 32.225
US - Stati Uniti d'America 3.083
SG - Singapore 1.826
CN - Cina 1.097
VN - Vietnam 833
FR - Francia 286
BR - Brasile 250
BD - Bangladesh 220
HK - Hong Kong 167
CA - Canada 92
FI - Finlandia 78
DE - Germania 75
GB - Regno Unito 70
JP - Giappone 61
AR - Argentina 59
MX - Messico 49
IN - India 47
IQ - Iraq 44
ID - Indonesia 35
PH - Filippine 25
CH - Svizzera 24
ZA - Sudafrica 24
ES - Italia 21
PK - Pakistan 21
NL - Olanda 20
CO - Colombia 19
TR - Turchia 19
UA - Ucraina 19
EC - Ecuador 18
CL - Cile 16
IE - Irlanda 15
RU - Federazione Russa 15
TH - Thailandia 15
VE - Venezuela 15
DZ - Algeria 13
PY - Paraguay 13
UZ - Uzbekistan 13
AT - Austria 12
SA - Arabia Saudita 12
AU - Australia 11
JM - Giamaica 11
TN - Tunisia 11
MA - Marocco 10
PL - Polonia 10
TW - Taiwan 10
BE - Belgio 9
MY - Malesia 9
UY - Uruguay 9
CR - Costa Rica 8
KE - Kenya 7
KR - Corea 7
EG - Egitto 6
JO - Giordania 6
RS - Serbia 6
SN - Senegal 6
AL - Albania 5
CZ - Repubblica Ceca 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
BH - Bahrain 4
DK - Danimarca 4
HR - Croazia 4
LB - Libano 4
PT - Portogallo 4
SI - Slovenia 4
AZ - Azerbaigian 3
BY - Bielorussia 3
GT - Guatemala 3
HU - Ungheria 3
KZ - Kazakistan 3
NG - Nigeria 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
SV - El Salvador 3
AM - Armenia 2
BO - Bolivia 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
KW - Kuwait 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GF - Guiana Francese 1
Totale 41.194
Salva come PNG Salva come JPEG
Città #
Genova 15.507
Genoa 10.434
Rapallo 3.133
Vado Ligure 2.716
Singapore 942
San Jose 766
Ashburn 526
Ho Chi Minh City 277
Lauterbourg 246
Beijing 199
Hanoi 194
New York 164
Hong Kong 152
Los Angeles 115
Santa Clara 109
Council Bluffs 101
Dallas 101
Bordighera 97
Helsinki 74
Orem 67
Frankfurt am Main 58
Tokyo 52
San Francisco 38
Buffalo 33
São Paulo 33
Da Nang 30
Rome 30
Mexico City 29
Montreal 27
Haiphong 26
Milan 26
Atlanta 25
Denver 25
Chicago 23
Zurich 22
Brooklyn 21
Phoenix 21
London 18
Naples 18
Houston 17
Boardman 16
Johannesburg 16
City of London 15
Dublin 15
St Louis 15
Tianjin 15
Biên Hòa 14
Baghdad 13
Paris 13
Chennai 12
Phủ Lý 12
Santiago 12
Toronto 12
Turin 12
Amsterdam 11
Bắc Ninh 11
Ninh Bình 11
Bologna 10
Hải Dương 10
Palermo 10
Shanghai 10
Tashkent 10
Guangzhou 9
Miami 9
Thái Nguyên 9
Boston 8
Cardiff 8
Poplar 8
Quito 8
Seattle 8
Tunis 8
Vancouver 8
Brussels 7
Jakarta 7
Kingston 7
Lahore 7
Marseille 7
Piscataway 7
Rio de Janeiro 7
San Diego 7
San José 7
Warsaw 7
Bangkok 6
Belgrade 6
Caracas 6
Dakar 6
Florence 6
Kyiv 6
Madrid 6
Quảng Ngãi 6
Quận Ba 6
Sydney 6
Vienna 6
Acalanes Ridge 5
Amman 5
Asunción 5
Bari 5
Belo Horizonte 5
Bogotá 5
Cairo 5
Totale 37.021
Salva come PNG Salva come JPEG
Nome #
Mitochondrial Generated Redox Stress Differently Affects the Endoplasmic Reticulum of Circulating Lymphocytes and Monocytes in Treatment‐Naïve Hodgkin’s Lymphoma 685
1,25-Dihydroxy vitamin D and coronary microvascular function 380
18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: Inverse correlation between calcification density and mineral metabolic activity 269
A Positron Emission Tomography/Computed Tomography (PET/CT) Evaluation of Asymptomatic Abdominal Aortic Aneurysms: Another Point of View. 229
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT. 227
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study 221
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 214
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 212
Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study 206
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study 203
Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma 203
Amyloid positron emission tomography and cognitive reserve. 201
Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: A translational18F-FDG PET/CT observation 201
Neuroimaging findings in mild cognitive impairment 201
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 199
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission. 199
An H-TERT Mutated Skin Metastasis as First Occurrence in a Case of Follicular Thyroid Carcinoma 199
Adult Advanced Chronic Lymphocytic Leukemia: Computational Analysis of Whole-Body CT Documents a Bone Structure Alteration 197
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 197
Assessment of skeletal tumor load in metastasized castration-resistant prostate cancer patients: A review of available methods and an overview on future perspectives 197
Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging. 196
Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery. 195
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 195
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 194
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 189
Intrabone Transplant of Cord Blood Stem Cells Establishes a Local Engraftment Store: A Functional PET/FDG Study 188
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 186
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 186
FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study 185
Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study. 183
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 183
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 183
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 181
A new frontier for amyloid PET imaging: multiple sclerosis 181
Trafficking and homing of systemically administered stem cells: the need for appropriate analysis tools of radionuclide images 179
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 179
G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells 179
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 179
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 178
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 178
Increased myocardial 18 F-FDG uptake as a marker of Doxorubicin-induced oxidative stress 176
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 176
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline 175
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 175
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 174
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. 174
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 174
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 173
Early identification of MCI converting to AD: a FDG PET study 173
Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis 172
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 172
18f-fluorodeoxyglucose positron emission tomography tracks the heterogeneous brain susceptibility to the hyperglycemia-related redox stress 171
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 169
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 169
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 168
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score. 168
A kinetics-based approach to amyloid PET semi-quantification 167
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence 167
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC) 166
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 163
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 163
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 163
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 162
What predicts cognitive decline in de novo Parkinson's disease? 162
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 162
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 162
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 161
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 160
Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis 160
High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography 159
Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution 159
Prevention of systemic toxicity in hyperthermic isolated lung perfusion using radioisotopic leakage monitoring 159
Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions 158
Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells. 157
A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility 157
Progressive disgregation of brain networking from normal aging to Alzhimer's Disease. Independent Component Analysis on FDG-PET data 156
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment 154
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 154
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 152
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 152
A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia 152
Witnessing ischemia or proofing coronary atherosclerosis: two different windows on the same or on different pathways precipitating cardiovascular events? 152
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 151
Brain glucose metabolism and cognitive function in patients with amnestic Mild Cognitive Impairment (MCI) 151
Brain glucose metabolism heterogeneity in idiopathic REM sleep behavior disorder and in Parkinson's disease 151
Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images 151
Bilateral motor and premotor cortex hypometabolism in a case of Mills syndrome 150
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 150
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 149
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 149
Correlazioni SPECT-neuropsicologia nella malattia di Alzheimer iniziale 149
New tracers and new perspectives for molecular imaging in Lewy body diseases 149
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 148
The role of the serotonergic system in REM sleep behavior disorder 148
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 148
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. 148
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab 148
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 147
Functional imaging in pre-motor Parkinson's disease 147
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 147
Totale 18.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.654
article - articoli 126.891
book - libri 0
conference - conferenze 13.494
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.269
Totale 289.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021200 0 0 0 0 0 0 0 0 0 0 0 200
2021/20223.276 82 114 231 380 149 274 136 676 263 347 142 482
2022/20233.660 300 318 63 370 531 558 34 329 583 86 442 46
2023/20242.386 115 253 41 315 191 450 160 161 105 72 120 403
2024/20257.067 270 499 200 501 843 720 646 1.220 308 345 722 793
2025/202612.760 1.678 403 722 888 1.597 902 1.855 595 1.194 1.229 1.432 265
Totale 41.980